Literature DB >> 35619558

Perioperative arginine prevents metastases by accelerating natural killer cell recovery after surgery.

Leonard Angka1, Christiano Tanese de Souza2, Katherine E Baxter2, Sarwat T Khan2, Marisa Market1, Andre B Martel3, Lee-Hwa Tai4, Michael A Kennedy2, John C Bell1, Rebecca C Auer5.   

Abstract

Profound natural killer (NK) cell suppression after cancer surgery is a main driver of metastases and recurrence, for which there is no clinically approved intervention available. Surgical stress is known to cause systemic postoperative changes that negatively modulate NK cell function including the expansion of surgery-induced myeloid-derived suppressor cells (Sx-MDSCs) and a marked reduction in arginine bioavailability. In this study, we determine that Sx-MDSCs regulate systemic arginine levels in the postoperative period and that restoring arginine imbalance after surgery by dietary intake alone was sufficient to significantly reduce surgery-induced metastases in our preclinical murine models. Importantly, the effects of perioperative arginine were dependent upon NK cells. Although perioperative arginine did not prevent immediate NK cell immunoparalysis after surgery, it did accelerate their return to preoperative cytotoxicity, interferon gamma secretion, and activating receptor expression. Finally, in a cohort of patients with colorectal cancer, postoperative arginine levels were shown to correlate with their Sx-MDSC levels. Therefore, this study lends further support for the use of perioperative arginine supplementation by improving NK cell recovery after surgery.
Copyright © 2022 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  arginine; colorectal cancer; immunology; immunotherapy; metastasis; myeloid-derived suppressor cells; natural killer cells; surgery; surgical oncology

Mesh:

Substances:

Year:  2022        PMID: 35619558      PMCID: PMC9552810          DOI: 10.1016/j.ymthe.2022.05.024

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   12.910


  64 in total

Review 1.  Perioperative use of arginine-supplemented diets: a systematic review of the evidence.

Authors:  John W Drover; Rupinder Dhaliwal; Lindsay Weitzel; Paul E Wischmeyer; Juan B Ochoa; Daren K Heyland
Journal:  J Am Coll Surg       Date:  2011-01-17       Impact factor: 6.113

2.  A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity.

Authors:  Fadi Kandarian; Gemalene M Sunga; Diana Arango-Saenz; Maura Rossetti
Journal:  J Vis Exp       Date:  2017-08-09       Impact factor: 1.355

3.  Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.

Authors:  Paulo C Rodriguez; Marc S Ernstoff; Claudia Hernandez; Michael Atkins; Jovanny Zabaleta; Rosa Sierra; Augusto C Ochoa
Journal:  Cancer Res       Date:  2009-02-05       Impact factor: 12.701

Review 4.  Myeloid-derived suppressor cells as regulators of the immune system.

Authors:  Dmitry I Gabrilovich; Srinivas Nagaraj
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

Review 5.  Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase.

Authors:  Nicolas Boissel; Leonard S Sender
Journal:  J Adolesc Young Adult Oncol       Date:  2015-09       Impact factor: 2.223

6.  Invasive Surgery Impairs the Regulatory Function of Human CD56 bright Natural Killer Cells in Response to Staphylococcus aureus. Suppression of Interferon-γ Synthesis.

Authors:  Renate Reinhardt; Stephanie Pohlmann; Holger Kleinertz; Monika Hepner-Schefczyk; Andreas Paul; Stefanie B Flohé
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

Review 7.  Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages.

Authors:  Meera Rath; Ingrid Müller; Pascale Kropf; Ellen I Closs; Markus Munder
Journal:  Front Immunol       Date:  2014-10-27       Impact factor: 7.561

8.  L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo.

Authors:  Yu Cao; Yonghui Feng; Yanjun Zhang; Xiaotong Zhu; Feng Jin
Journal:  BMC Cancer       Date:  2016-06-01       Impact factor: 4.430

Review 9.  What Fuels Natural Killers? Metabolism and NK Cell Responses.

Authors:  Clair M Gardiner; David K Finlay
Journal:  Front Immunol       Date:  2017-04-03       Impact factor: 7.561

10.  Local arginase 1 activity is required for cutaneous wound healing.

Authors:  Laura Campbell; Charis R Saville; Peter J Murray; Sheena M Cruickshank; Matthew J Hardman
Journal:  J Invest Dermatol       Date:  2013-04-03       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.